News
E-Cigarettes to Quit Smoking May Not Result in Success
Study reveals other smoking cessation aids are tied to more successful quits
Your search for smoking cessation returned 16 results
News
Cytisine Not Noninferior to Varenicline for Smoking Cessation
Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group.
Safety Alerts and Recalls
FDA Takes Steps to Maintain Supply of Smoking Cessation Therapy
N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
MPR Weekly Dose Podcast
MPR Weekly Dose Podcast Episode 85
This week Pfizer recalled their smoking cessation therapy Chantix. A treatment for acute bacterial skin and skin structure infections becomes available. Aduhelm, the newly approved Alzheimer Disease treatment, has its label updated. A blood lead level test is recalled, and there's updates to the cancer drug Keytruda.
Safety Alerts and Recalls
Pfizer Expands Chantix Recall Due to Nitrosamine Impurity
To date, the Company has not received any reports of adverse events related to this recall.
News
Varenicline Combo, Extension No Better for Quitting Smoking
Combining varenicline with nicotine patch, extending treatment from 12 to 24 weeks did not increase smoking cessation rates
News
FDA Proposes Ban on Menthol Cigarettes, Flavored Cigars
Research has shown that menthol cigarettes are harder to quit than traditional tobacco products
Generics News
First Generic Version of Chantix Now Available
Par's generic version of Chantix is currently the only available one in the US.
News, Safety Alerts and Recalls
Chantix Recalled, Distribution Halted Over Nitrosamine Impurity
Long-term use of a product containing N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
News
E-Cigarettes May Up the Risk for Erectile Dysfunction
Findings for men between 20 and 65 years of age with no prior history of cardiovascular disease
